Estell buys ACHN 9.79: Deutsche Bank Upgrades Achillion Pharmaceuticals to âBuyâ (ACHN)
Deutsche Bank upgraded shares of Achillion Pharmaceuticals (NASDAQ:ACHN) from a hold rating to a buy rating in a research report sent to investors on Monday morning, TheFlyOnTheWall.com reports. They currently have $17.00 target price on the stock ... ...
30 people liked this
0 Comments:
Post a Comment
Subscribe to Post Comments [Atom]
<< Home